RVL Pharmaceuticals plc

The momentum for this stock is not very good. RVL Pharmaceuticals plc is not very popular among insiders. Tradey thinks it is not wise to invest in RVL Pharmaceuticals plc.
Log in to see more information.
RVLP Fundamental Data by TradingView

News

RVL Pharmaceuticals announces prepackaged reorganization of certain U.S. units
RVL Pharmaceuticals announces prepackaged reorganization of certain U.S. units

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?
Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nRVL Pharmaceuticals stock is a hot topic on Friday as investors seek answers as to why RVLP stock is rally alongside heavy trading.\nThe...\n more…

RVL Pharmaceuticals files to sell 11.87M shares of common stock for holders
RVL Pharmaceuticals files to sell 11.87M shares of common stock for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Globe Newswire BRIDGEWATER, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (RVL or the Company), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a fireside chat and host 1x1 investor meetings at the H.C. ...\n more…

RVL Pharmaceuticals (RVLP) Gets a Buy from H.C. Wainwright
RVL Pharmaceuticals (RVLP) Gets a Buy from H.C. Wainwright

TipRanks Financial Blog no summary\n more…

RVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
RVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…